Blog
-
-
When We Put AI in Medical Devices, Magic Starts to Happen
-
‘Welcome to scrutiny’: BIO chair mounts defense against more rigorous accelerated approval process
-
AMS 2021 Specialty Drug Trends Report Highlights Lack of Transparency
-
5 FDA decisions to watch in the third quarter
-
Pandemic Gave Clues to Cause of Rare Heart Condition in Kids
-
Cost of Brand-Name Epilepsy Meds Is Soaring
-
Vertex, CRISPR strengthen case for pioneering gene-editing treatment
-
Prices of new drugs have soared. Will legislation be able to stop it?
-
In Reversal, FTC Launches Inquiry Into PBM Industry